Biotech Mesoblast Achieves Major Milestone Completing Patient Treatment in Pivotal Phase 3 Trial for Chronic Low Back Pain August 16, 2026
Mining Endeavour Silver Reports an Illegal Blockade and Suspension of Operations at its Terronera Mine August 16, 2026
Biotech argenx Announces Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis August 16, 2026
Technology authID Reports Second Quarter 2026 Financial Results and Announces Evaluation of Strategic and Financing Alternatives August 14, 2026